Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis (Q50073755)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 January 2007

Language	Label	Description	Also known as
English	Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis	scientific article published on 22 January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Salmonella enterica

0 references

0 references

1 reference

based on heuristic

inferred from title

Lacticaseibacillus casei

1 reference

based on heuristic

inferred from title

Salmonella enteritidis

object named as

Salmonella enterica serovar Enteritidis

1 reference

based on heuristic

inferred from title

author name string

Akinobu Kajikawa

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Eiichi Satoh

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Rob J Leer

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Shigeki Yamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Shizunobu Igimi

5

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

language of work or name

0 references

publication date

22 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

25

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

18

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

3599-3605

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Long-term immunological memory induced by recombinant oral Salmonella vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Responses to the soluble flagellar protein FliC are Th2, while those to FliC on Salmonella are Th1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Lactobacilli as vehicles for targeting antigens to mucosal tissues by surface exposition of foreign antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Probiotic Lactobacillus casei activates innate immunity via NF-kappaB and p38 MAP kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT9029 in Wistar and Brown Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

based on heuristic

inferred from DOI database lookup

Method for the isolation of highly purified Salmonella flagellins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.055

7 January 2021

based on heuristic

inferred from DOI database lookup

Associations between nasal torquetenovirus load and spirometric indices in children with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17287050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2007.01.055

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/17287050

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50073755&oldid=2238246150"